Is IVCTF or MRK a better dividend investment in 2026?

IVCTF currently yields 4938.27% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: IVCTF offers higher current income.

What is the dividend yield difference between IVCTF and MRK?

IVCTF has a forward dividend yield of 4938.27% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 4935.51 percentage points.

Home › Compare › IVCTF vs MRK

IVCTF vs MRK: Dividend Comparison 2026

IVCTF yields 4938.27% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 IVCTF wins by $55146348937607.19M in total portfolio value

INVESTMENT

TIME HORIZON10 years

IVCTF

● Live price

4938.27%

Share price

$0.04

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$55146348937607.24M

Annual income

$53,033,758,961,414,200,000.00

Full IVCTF calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — IVCTF vs MRK

📍 IVCTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	IVCTF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, IVCTF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

IVCTF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IVCTF

Annual income on $10K today (after 15% tax)

$419,753.09/yr

After 10yr DRIP, annual income (after tax)

$45,078,695,117,202,070,000.00/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, IVCTF beats the other by $45,078,695,117,202,060,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IVCTF + MRK for your $10,000?

IVCTF: 50%MRK: 50%

100% MRK50/50100% IVCTF

Portfolio after 10yr

$27573174468803.65M

Annual income

$26,516,879,480,707,105,000.00/yr

Blended yield

96.17%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

IVCTF

No analyst data

Altman Z

32.4

Piotroski

3/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IVCTF buys

MRK buys

No recent congressional trades found for IVCTF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricIVCTFMRK

Forward yield	4938.27% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$55146348937607.24M ✓	$56.8K
Annual income after 10y	$53,033,758,961,414,200,000.00 ✓	$9,798.13
Total dividends collected	$55003355952995.54M ✓	$28.9K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: IVCTF vs MRK ($10,000, DRIP)

Year	IVCTF Portfolio	IVCTF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$504,527	$493,827.16	$11,206	$366.19	+$493.3K → IVCTF
2	$23,824,817	$23,284,973.37	$12,650	$502.35	+$23.81M → IVCTF
3	$1,053,123,085	$1,027,630,530.32	$14,407	$694.19	+$1053.11M → IVCTF
4	$43,579,292,978	$42,452,451,277.21	$16,585	$967.82	+$43579.28M → IVCTF
5	$1,688,429,051,261	$1,641,799,207,774.13	$19,342	$1,363.89	+$1688429.03M → IVCTF
6	$61,254,845,187,941	$59,448,226,103,092.12	$22,913	$1,947.19	+$61254845.17M → IVCTF
7	$2,081,181,684,947,090	$2,015,639,000,595,993.00	$27,662	$2,823.89	+$2081181684.92M → IVCTF
8	$66,229,598,087,621,200	$64,002,733,684,727,816.00	$34,159	$4,173.35	+$66229598087.59M → IVCTF
9	$1,974,383,155,320,608,300	$1,903,517,485,366,853,600.00	$43,337	$6,308.80	+$1974383155320.56M → IVCTF
10	$55,146,348,937,607,240,000	$53,033,758,961,414,200,000.00	$56,776	$9,798.13	+$55146348937607.19M → IVCTF

IVCTF vs MRK: Complete Analysis 2026

IVCTF — Stock

Invictus Energy Limited, an independent upstream oil and gas company, engages in the exploration and appraisal of the Cabora Bassa project. It holds 80% interest in SG 4571 that covers an area of 360,000 hectares located in the Cabora Bassa Basin in northern Zimbabwe. The company was formerly known as Interpose Holdings Limited and changed its name to Invictus Energy Limited in June 2018. Invictus Energy Limited was incorporated in 2011 and is headquartered in West Perth, Australia.

Full IVCTF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this IVCTF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IVCTF vs SCHD IVCTF vs JEPI IVCTF vs O IVCTF vs KO IVCTF vs MAIN IVCTF vs JNJ IVCTF vs ABBV IVCTF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.